Citations

Clear

7551 citation(s) found for "Ho, Matthew".

Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis
Ji, Xuemei , Ciavatta, Dominic J. , Pinder, Benjamin D. , Zhao, Ai, Zhang, Jinyi , Tadesse, Yohannes, Qian, David C. , Nair, Rajan P. , Tsoi, Lam C. , Carette, Simon , Cuthbertson, David , Davis, John C. , Dellaripa, Paul F., Forbess, Lindsy, Gewurz‐Singer, Ora, Hoffman, Gary S., Koening, Curry L. , Langford, Carol A. , Mahr, Alfred , McAlear, Carol A. , Moreland, Larry W. , Seo, Philip , Sreih, Antoine G. , Clair, E. William St. , Stone, John H., Ytterberg, Steven R. , Elder, James T. , Qu, Jia , Ochi, Toshiki , Hirano, Naoto , Edberg, Jeffrey C., Falk, Ronald J. , Siminovitch, Katherine A. , Merkel, Peter A. , Xie, Gang , Monach, Paul A. , Byun, Jinyoung , Weirauch, Matthew T. , Pagnoux, Christian , Chung, Sharon A. , Dellaripa, Paul F. , Khalidi, Nader , Specks, Ulrich , Spiera, Robert , Amos, Christopher I. , Mahr, Alfred , Moreland, Larry W , Tsoi, Lam C

Mayo Clinic

Arthritis & Rheumatology | December 28, 2016 | Volume: 69 | Issue: 5 | Pages: 1054-1066

10.1002/art.40034 | PMID 28029757 Get It

Objective To identify risk alleles relevant to the causal and biologic mechanisms of antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV). Methods A genome‐wide association study and subsequent replication study were conducted in a total cohort of 1,986 cases of AAV (patients with granulomatosis with polyangiitis [Wegener's] [GPA] or microscopic polyangiitis [MPA]) and 4,723 healthy controls. Meta‐analysis of these data sets and functional annotation of identified risk loci were performed, and candidate disease variants with unknown functional effects were investigated for their impact on gene expression and/or protein function. Results Among the genome‐wide significant associations identified, the largest effect on risk of AAV came from the single‐nucleotide polymorphism variants rs141530233 and rs1042169 at the HLA–DPB1 locus (odds ratio [OR] 2.99 and OR 2.82, respectively) which, together with a third variant, rs386699872, constitute a triallelic risk haplotype associated with reduced expression of the HLA–DPB1 gene and HLA–DP protein in B cells and monocytes and with increased frequency of complementary proteinase 3 (PR3)–reactive T cells relative to that in carriers of the protective haplotype. Significant associations were also observed at the SERPINA1 and PTPN22 loci, the peak signals arising from functionally relevant missense variants, and at PRTN3 , in which the top‐scoring variant correlated with increased PRTN3 expression in neutrophils. Effects of individual loci on AAV risk differed between patients with GPA and those with MPA or between patients with PR3‐ANCAs and those with myeloperoxidase‐ANCAs, but the collective population attributable fraction for these variants was substantive, at 77%. Conclusion This study reveals the association of susceptibility to GPA and MPA with functional gene variants that explain much of the genetic etiology of AAV, could influence and possibly be predictors of the clinical presentation, and appear to alter immune cell proteins and responses likely to be key factors in the pathogenesis of AAV.
Tau‐PET uptake: Regional variation in average SUVR and impact of amyloid deposition
Vemuri, Prashanthi , Lowe, Val J. , Senjem, Matthew L. , Kemp, Bradley J. , Schwarz, Christopher G. , Przybelski, Scott A. , Petersen, Ronald C. , Knopman, David S. , Machulda, Mary M. , Jack, Clifford R. , Schwarz, Christopher G , Vemuri, Prashanthi , Senjem, Matthew L

Mayo Clinic

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | December 22, 2016 | Volume: 6 | Issue: 1 | Pages: 21-30

10.1016/j.dadm.2016.12.010 | PMID 28138510 Get It

AbstractIntroductionTau‐positron emission tomography (PET) imaging with AV1451 is sensitive to Alzheimer disease (AD)–related tau deposition in the brain. We (1) examined regional variation of average tau‐PET standardized uptake value ratios (SUVRs) in a young normal population (30–49 years) and corrected for the regional variability and (2) tested if the standardized values (z‐scores) scaled appropriately to capture regional Alzheimer‐specific (i.e., amyloid sensitive) tau‐PET changes in individuals aged 50+ years.MethodsWe identified 490 individuals (70 between 30–49 years as a reference group and 420 cognitively normal between 50–95 years of age) with tau‐PET and amyloid PET scans from the Mayo Clinic Study of Aging.ResultsThere was intrinsic regional variability in average tau‐PET SUVR with uptakes higher in some regions than others, even in the younger individuals who would have minimal or no neurofibrillary tangles. We corrected for this using region of interest–specific z‐scores based on the reference group. Amyloid and tau‐PET uptake were associated throughout the brain after adjusting for age, with the highest correlations in the medial temporal regions.DiscussionRegions with high‐average SUVR are not necessarily those with the greatest tau pathology. Standardization is therefore recommended. Standardization of the data “realigns” the data such that the regional tau z‐scores are informative of the disease process, that is, regions with high z‐scores now coincide with regions correlated with amyloid deposition. Medial temporal structures, specifically entorhinal cortex–tau, may be useful as an AD‐specific tau‐PET signature due to its sensitivity to amyloid.
Attenuation measuring ultrasound shearwave elastography and in vivo application in post-transplant liver patients
Nenadic, Ivan , Qiang, Bo, Zhao, Heng , Sánchez, William , Greenleaf, James F. , Chen, Shigao , Nenadic, Ivan Z, Urban, Matthew W. , Sanchez, William

Mayo Clinic

Physics in Medicine & Biology | December 21, 2016 | Volume: 62 | Issue: 2 | Pages: 484-500

10.1088/1361-6560/aa4f6f | PMID 28000623 Get It

Abstract Ultrasound and magnetic resonance elastography techniques are used to assess mechanical properties of soft tissues. Tissue stiffness is related to various pathologies such as fibrosis, loss of compliance, and cancer. One way to perform elastography is measuring shear wave velocity of propagating waves in tissue induced by intrinsic motion or an external source of vibration, and relating the shear wave velocity to tissue elasticity. All tissues are inherently viscoelastic and ignoring viscosity biases the velocity-based estimates of elasticity and ignores a potentially important parameter of tissue health. We present attenuation measuring ultrasound shearwave elastography (AMUSE), a technique that independently measures both shear wave velocity and attenuation in tissue and therefore allows characterization of viscoelasticity without using a rheological model. The theoretical basis for AMUSE is first derived and validated in finite element simulations. AMUSE is validated against the traditional methods for assessing shear wave velocity (phase gradient) and attenuation (amplitude decay) in tissue mimicking phantoms and excised tissue. The results agreed within one standard deviation. AMUSE was used to measure shear wave velocity and attenuation in 15 transplanted livers in patients with potential acute rejection, and the results were compared with the biopsy findings in a preliminary study. The comparison showed excellent agreement and suggests that AMUSE can be used to separate transplanted livers with acute rejection from livers with no rejection.
Genetic variation at 16q24.2 is associated with small vessel stroke
Traylor, Matthew , Nalls, Mike A., Cotlarciuc, Ioana, Radmanesh, Farid , Hanscombe, Ken B. , Langefeld, Carl D. , Saleheen, Danish , Rost, Natalia S. , Yet, İdil , Spector, Tim D. , Bell, Jordana T. , Hannon, Eilís , Mill, Jonathan , Chauhan, Ganesh , Debette, Stéphanie , Bis, Joshua C. , Longstreth, W.T. , Seshadri, Sudha , Hamilton‐Bruce, Monica Anne , Jiménez-Conde, Jordi , Schmidt, Reinhold, Słowik, Agnieszka , Lemmens, Robin , Lindgren, Arne, Melander, Olle , Grewal, Raji P., Sacco, Ralph L., Rexrode, Kathryn M. , Arnett, Donna K. , Johnson, Julie A. , Benavente, Oscar, Wasssertheil‐Smoller, Sylvia, Lee, Jin‐Moo , Pulit, Sara L. , Wong, Quenna , Rich, Stephen S. , Bakker, Paul I. W. de , McArdle, Patrick F. , Woo, Daniel , Anderson, Christopher D. , Xu, Huichun , Heitsch, Laura , Fornage, Myriam , Stefansson, Kari, Þorsteinsdóttir, Unnur , Grétarsdóttir, Sólveig , Lewis, Cathryn M. , Sudlow, Cathie , Rothwell, Peter M. , Boncoraglio, Giorgio B. , Thijs, Vincent , Levi, Christopher , Kittner, Steven J. , Dichgans, Martin , Worrall, Bradford B. , Markus, Hugh S. , Malik, Rainer , Þorleifsson, Guðmar , Ikram, M. Arfan , Launer, Lenore J. , Cole, John W. , Lindgren, Arne, Rundek, Tatjana , Jern, Christina , Stefansson, Kari, Lewis, Cathryn M , Sharma, Pankaj Kumar , Meschia, James F. , Rosand, Jonathan M. , Mitchell, Braxton D. , Dichgans, Martin , Rich, Stephen S , Seshadri, Sudha , Debette, Stephanie , Lemmens, Robin , Arnett, Donna K , Lee, Jin-Moo

Mayo Clinic

Annals of Neurology | December 20, 2016 | Volume: 81 | Issue: 3 | Pages: 383-394

10.1002/ana.24840 | PMID 27997041 Get It

Objective Genome‐wide association studies (GWAS) have been successful at identifying associations with stroke and stroke subtypes, but have not yet identified any associations solely with small vessel stroke (SVS). SVS comprises one quarter of all ischemic stroke and is a major manifestation of cerebral small vessel disease, the primary cause of vascular cognitive impairment. Studies across neurological traits have shown that younger‐onset cases have an increased genetic burden. We leveraged this increased genetic burden by performing an age‐at‐onset informed GWAS meta‐analysis, including a large younger‐onset SVS population, to identify novel associations with stroke. Methods We used a three‐stage age‐at‐onset informed GWAS to identify novel genetic variants associated with stroke. On identifying a novel locus associated with SVS, we assessed its influence on other small vessel disease phenotypes, as well as on messenger RNA (mRNA) expression of nearby genes, and on DNA methylation of nearby CpG sites in whole blood and in the fetal brain. Results We identified an association with SVS in 4,203 cases and 50,728 controls on chromosome 16q24.2 (odds ratio [OR; 95% confidence interval {CI}] = 1.16 [1.10–1.22]; p = 3.2 × 10 −9 ). The lead single‐nucleotide polymorphism (rs12445022) was also associated with cerebral white matter hyperintensities (OR [95% CI] = 1.10 [1.05–1.16]; p = 5.3 × 10 −5 ; N = 3,670), but not intracerebral hemorrhage (OR [95% CI] = 0.97 [0.84–1.12]; p = 0.71; 1,545 cases, 1,481 controls). rs12445022 is associated with mRNA expression of ZCCHC14 in arterial tissues ( p = 9.4 × 10 −7 ) and DNA methylation at probe cg16596957 in whole blood ( p = 5.3 × 10 −6 ). Interpretation 16q24.2 is associated with SVS. Associations of the locus with expression of ZCCHC14 and DNA methylation suggest the locus acts through changes to regulatory elements. Ann Neurol 2017;81:383–394
Pediatric Sleep Duration Consensus Statement: A Step Forward
Paruthi, Shalini, Brooks, Lee J., D’Ambrosio, Carolyn, Hall, Wendy A. , Kotagal, Suresh , Lloyd, Robin M. , Malow, Beth A. , Nichols, Cynthia , Quan, Stuart F. , Rosen, Carol L. , Troester, Matthew M., Wise, Merrill S. , Maski, Kiran

Mayo Clinic

Journal of Clinical Sleep Medicine | December 14, 2016 | Volume: 12 | Issue: 12 | Pages: 1705-1706

10.5664/jcsm.6368 | PMID 27855732 Get It

Full-thickness oesophageal regeneration in pig using a polyurethane mucosal cell seeded graft
Barron, Matthew, Blanco, Ellen W., Aho, Johnathon M. , Chakroff, Jason, Cassivi, Stephen D. , Carey, William A., Wigle, Dennis A. , Barron, Matthew R, Johnson, Jed K.

Mayo Clinic

Journal of Tissue Engineering and Regenerative Medicine | December 14, 2016 | Volume: 12 | Issue: 1 | Pages: 175-185

10.1002/term.2386 | PMID 27966266 Get It

The Natural History of Petroclival Meningiomas: A Volumetric Study
Hunter, Jacob B. , Yawn, Robert J. , O’Connell, Brendan P., Carlson, Matthew L. , Mistry, Akshitkumar M. , Haynes, David S. , Thompson, Reid C., Weaver, Kyle D., Wanna, George B. , Wang, Ray , Hunter, Jacob B

Mayo Clinic

Otology & Neurotology | December 9, 2016 | Volume: 38 | Issue: 1 | Pages: 123-128

10.1097/mao.0000000000001260 | PMID 27941420 Get It

Objectives: This study characterizes primary petroclival meningioma growth rates, before intervention, using volumetric analysis. In addition, predictors of growth are analyzed. Methods: Patients with previously untreated petroclival meningiomas were retrospectively reviewed (1999–2015). Image analysis software was used to perform volumetric analyses of tumor size and growth. Three-dimensional segmentation volumetric analyses were compared with volumes estimated utilizing three orthogonal dimensions. Tumor growth was defined as a 15% increase in volume. Results: Thirty-four patients who underwent at least two magnetic resonance imaging (MRI) studies before intervention were included. The mean age was 55.2 years, and 65.7% were women. The mean tumor volume at presentation was 5.6 cm 3 (range, 0.1–25.8 cm 3 ) as determined from segmentation volumetric analysis. At a mean follow-up of 44.5 months (range, 3.7–125.1 mo), 88.2% of tumors grew. The mean annual volumetric growth rate was 2.38 cm 3 /yr (−0.63 to 25.9 cm 3 /yr). Tumor volume, T2 hyperintensity within the tumor, peritumoral edema, and ataxia and/or cerebellar symptoms at presentation were all significantly associated with greater rates of tumor growth. Ultimately, 10 (29.4%) patients underwent treatment during the follow-up period. Conclusion: Our experience demonstrates that the vast majority (88%) of untreated petroclival meningiomas grow; the mean volumetric growth rate was noted to be 2.38 cm 3 /yr. We found a significant association between increased growth rate and larger tumor size at diagnosis, T2 hyperintensity within the tumor, peritumoral edema, and the presence of ataxia and/or cerebellar symptoms.
A Dynamic Transmission Model to Evaluate the Effectiveness of Infection Control Strategies
Khader, Karim , Leecaster, Molly, Samore, Matthew H. , Thomas, Alun , Huskins, W. Charles , Zhang, Yue , Greene, Tom , Redd, Andrew Middleton

Mayo Clinic

Open Forum Infectious Diseases | December 9, 2016 | Volume: 4 | Issue: 1 | Pages: No page available

10.1093/ofid/ofw247 | PMID 28702465 Get It

Abstract Background The advancement of knowledge about control of antibiotic resistance depends on the rigorous evaluation of alternative intervention strategies. The STAR*ICU trial examined the effects of active surveillance and expanded barrier precautions on acquisition of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) in intensive care units. We report a reanalyses of the STAR*ICU trial using a Bayesian transmission modeling framework. Methods The data included admission and discharge times and surveillance test times and results. Markov chain Monte Carlo stochastic integration was used to estimate the transmission rate, importation, false negativity, and clearance separately for MRSA and VRE. The primary outcome was the intervention effect, which when less than (or greater than) zero, indicated a decreased (or increased) transmission rate attributable to the intervention. Results The transmission rate increased in both arms from pre- to postintervention (by 20% and 26% for MRSA and VRE). The estimated intervention effect was 0.00 (95% confidence interval [CI], −0.57 to 0.56) for MRSA and 0.05 (95% CI, −0.39 to 0.48) for VRE. Compared with MRSA, VRE had a higher transmission rate (preintervention, 0.0069 vs 0.0039; postintervention, 0.0087 vs 0.0046), higher importation probability (0.22 vs 0.17), and a lower clearance rate per colonized patient-day (0.016 vs 0.035). Conclusions Transmission rates in the 2 treatment arms were statistically indistinguishable from the pre- to postintervention phase, consistent with the original analysis of the STAR*ICU trial. Our statistical framework was able to disentangle transmission from importation and account for imperfect testing. Epidemiological differences between VRE and MRSA were revealed.
A kidney transplant recipient with renal medullary viral cytopathic changes
Ramanan, Poornima , Timmerman, Elizabeth A., Fidler, Mary E., Amer, Hatem , Pritt, Bobbi S. , Schwab, Dale A. , Batterman, Hollis J., Binnicker, Matthew J. , Amer, Hatem , Pritt, Bobbi S

Mayo Clinic

Transplant Infectious Disease | December 7, 2016 | Volume: 19 | Issue: 1 | Pages: No page available

10.1111/tid.12646 | PMID 27925350 Get It

AbstractWe present a case of JC polyomavirus (JCV)‐associated nephropathy (PyVAN) in an asymptomatic deceased‐donor kidney transplant recipient. Despite the presence of viral cytopathic effect in the kidney biopsy and positive BK polyomavirus (BKV) in situ hybridization (ISH), BKV real‐time polymerase chain reaction (PCR) results of plasma and urine were negative. JCV ISH was performed and was found to be positive. JCV real‐time PCR on urine, plasma, and the kidney biopsy tissue was positive. Reduction in immunosuppression resulted in resolution of JCV viremia. This case highlights that JC‐PyVAN is a distinct clinical entity and is likely to have a better clinical outcome than BK‐PyVAN. Concurrent infection with BKV and JCV may occur, but may be difficult to confirm due to the potential for cross‐reactivity between BKV and JCV ISH stains.